个人简历

学历背景：
2003.9－2007.7 上海水产大学，生物技术（海洋生物制药），理学学士
2007.9－2012.7 复旦大学，药剂学，理学博士
国外学习研究经历：
2012.9－2015.12 耶鲁大学，医学院，博士后
工作经历：
2015.12－2016.4 哈尔滨工业大学，生命科学与技术学院，副教授
2016.4－至今 苏州大学，药学院，特聘副教授

研究领域

1、脑转移瘤靶向药物递送系统；
2、新型给药系统在代谢性疾病中的应用

近期论文

1. Han L, Cai Q, Tian D, Kong DK, Gou X, Chen Z, Strittmatter SM, Wang Z, Sheth KN, Zhou J. Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles. Nanomedicine. 2016 Mar 30. pii: S1549-9634(16)30018-1. (SCI收录一区，IF 6.155)
2. Han L, Kong DK, Zheng MQ, Murikinati S, Ma C, Yuan P, Li L, Tian D, Cai Q, Ye C, Holden D, Park JH, Gao X, Thomas JL, Grutzendler J, Carson RE, Huang Y, Piepmeier JM, Zhou J. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging. ACS Nano. 2016 Apr 26;10(4):4209-18. (SCI收录一区，IF 12.881)
3. Han L, Liu M, Ye D, Zhang N, Lim E, Lu J, Jiang C. Tumor cell membrane-targeting pH-dependent electron donor-acceptor fluorescence systems with low background signals. Biomaterials. 2014 Mar;35(9):2952-60. (SCI收录一区，IF 8.557)
4. Han L, Guo Y, Ma H, He X, Kuang Y, Zhang N, Lim E, Zhou W, Jiang C. Acid Active Receptor-Specific Peptide Ligand for In Vivo Tumor-Targeted Delivery. Small. 2013 Nov 11;9(21):3647-58. (SCI收录一区，IF 8.368) Highlighted by “Materials views China”
5. Han L, Ma H, Guo Y, Kuang Y, He X, Jiang C. pH-Controlled Delivery of Nanoparticles into Tumor Cells. Adv Healthc Mater. 2013 Nov;2(11):1435-9. (SCI收录一区，IF 5.797)
6. Han L, Li JF, Huang SX, Huang RQ, Liu SH, Hu X, Yi PW, Shan D, Wang XX, Lei H, Jiang C. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Biomaterials. 2011;32(11):2989-98. (SCI收录一区，IF 8.557)
7. Han L, Huang R, Li J, Liu S, Huang S, Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials. 2011;32(4):1242-52. (SCI收录一区，IF 8.557)
8. Han L, Huang R, Liu S, Huang S, Jiang C. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Mol Pharm. 2010;7(6):2156-65. (SCI收录二区，IF 4.384)
9. Huang RQ*, Han L*, Li JH, RenFL, Ke WL, Jiang C, Pei YY. Neuroprotection in a 6-OHDA-lesioned Parkinson model using Lactoferrin-modified Nanoparticles. J Gene Med. 2009, 11(9):754-63. (*共同一作，SCI收录三区，IF 2.472)